ALBUTEROL SULFATE Recall D-1019-2022
Description: Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 5 x 3 mL unit-dose vials, Rx only, Manufactured by: Nephron Pharma, NDC 0487-9501-03
ALBUTEROL SULFATE Recall D-1019-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-1019-2022 |
Event ID | 89646 |
Brand | ALBUTEROL SULFATE |
Generic Name | ALBUTEROL SULFATE |
Manufacturer | ALBUTEROL SULFATE |
Original Package? | 1 |
Active Substance | ALBUTEROL SULFATE |
Drug Route | RESPIRATORY (INHALATION) |
Distribution | USA nationwide. |
Quantity | 23 pouches |
Recall Reason | cGMP deviations: Temperature abuse |
Drug Classification | Class II |
Drug Code Info | 20220615 |
Product NDC | 0487-9501 |
Drug UPC | 0304879501003 0304879501010 |
Recall Initiation Date | 20220413 |
Report Date | 20220615 |
Classification Date | 20220609 |
Address | 9954 Maryland DriveDeep Run Iii Ste. 4000 Richmond, VA 23233 United States |
Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
Initial Notification | Letter |
Unique Ingredient Identifier | 021SEF3731 |
Drug Application Number | ANDA074880 |
Structured Product Labeling (SPL ID) | b8a75428-95af-d867-e053-2a95a90a6509 |
Structured Product Labeling (SPL Set ID) | 574824f3-51cc-4b94-9c10-e3204d8b19f8 |
Similar To |